Rhumbline Advisers Acquires 852 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

Rhumbline Advisers raised its holdings in SI-BONE, Inc. (NASDAQ:SIBN) by 1.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,419 shares of the company’s stock after buying an additional 852 shares during the quarter. Rhumbline Advisers owned 0.14% of SI-BONE worth $768,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in SI-BONE by 24.7% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,649 shares of the company’s stock valued at $138,000 after buying an additional 2,108 shares during the period. RiverPark Advisors LLC grew its holdings in shares of SI-BONE by 260.4% in the 1st quarter. RiverPark Advisors LLC now owns 11,357 shares of the company’s stock worth $186,000 after purchasing an additional 8,206 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of SI-BONE in the 2nd quarter worth about $152,000. EntryPoint Capital LLC grew its holdings in shares of SI-BONE by 78.4% in the 1st quarter. EntryPoint Capital LLC now owns 13,906 shares of the company’s stock worth $228,000 after purchasing an additional 6,113 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of SI-BONE by 7.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 20,494 shares of the company’s stock worth $336,000 after purchasing an additional 1,372 shares during the last quarter. Institutional investors own 98.11% of the company’s stock.

SI-BONE Stock Performance

SI-BONE stock opened at $14.85 on Tuesday. The company has a current ratio of 9.17, a quick ratio of 8.12 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 1 year low of $11.76 and a 1 year high of $22.56. The company has a market cap of $611.89 million, a PE ratio of -13.62 and a beta of 1.22. The company’s 50-day moving average is $15.44 and its two-hundred day moving average is $14.84.

SI-BONE (NASDAQ:SIBN) last released its earnings results on Monday, August 5th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.04. SI-BONE had a negative net margin of 27.10% and a negative return on equity of 24.27%. The company had revenue of $39.97 million for the quarter, compared to the consensus estimate of $38.95 million. During the same period in the prior year, the company posted ($0.30) EPS. Equities analysts anticipate that SI-BONE, Inc. will post -0.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SIBN has been the topic of several analyst reports. Morgan Stanley lowered their target price on shares of SI-BONE from $21.00 to $19.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Needham & Company LLC reduced their price target on shares of SI-BONE from $27.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, August 6th. Finally, Truist Financial reduced their price target on shares of SI-BONE from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, August 6th. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $23.00.

Insider Buying and Selling at SI-BONE

In other SI-BONE news, insider Anthony J. Recupero sold 2,087 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $14.17, for a total transaction of $29,572.79. Following the transaction, the insider now directly owns 236,717 shares in the company, valued at approximately $3,354,279.89. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Anthony J. Recupero sold 3,905 shares of the company’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $13.84, for a total value of $54,045.20. Following the completion of the sale, the insider now directly owns 238,804 shares of the company’s stock, valued at approximately $3,305,047.36. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Anthony J. Recupero sold 2,087 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $14.17, for a total value of $29,572.79. Following the completion of the sale, the insider now directly owns 236,717 shares of the company’s stock, valued at $3,354,279.89. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,023 shares of company stock worth $347,749. Company insiders own 5.40% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.